Pathogenicity study in sheep using reverse-genetics-based reassortant bluetongue viruses. (2014)
Attributed to:
Realising the potential of a genetically engineered and uniquely cross protective vaccine for Bluetongue disease
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vetmic.2014.09.012
PubMed Identifier: 25307940
Publication URI: http://europepmc.org/abstract/MED/25307940
Type: Journal Article/Review
Volume: 174
Parent Publication: Veterinary microbiology
Issue: 1-2
ISSN: 0378-1135